Galmed Pharmaceuticals (GLMD) Q3 2026 Earnings

30JulConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.83
-0.66
-0.5
-0.33

Details

Expected EPS
-0.39
Actual EPS
N/A
Surprise EPS
0.39
Surprise Percent
+100%

Description

Galmed Pharmaceuticals (GLMD) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts